Making decisions about blood cancer and your fertility
Clinical psychologist Ela Sexton advises on a few steps you can take when considering blood cancer and fertility planning.
- Lifestyle and living well
Category: Stories
Fertility, family and blood cancer
Sage and Sophie had to quickly make decisions about fertility and whether to start their respective families in the future – all within days of receiving a blood cancer diagnosis.
- Acute lymphoblastic leukaemia
- Acute myeloid leukaemia
- Lifestyle and living well
Clinical trial for high-risk MDS tests new drug combination
A Phase I investigator-driven clinical trial, which is ready to recruit its first participant, gives Australian patients with high-risk MDS access to two new oral drugs.
- Clinical trials
- Myelodysplastic syndromes
- Research
Don had a stem cell transplant at 70 and says “exercise helped”
Don Hayes had an allogeneic stem cell transplant days before his 71st birthday.
- Myelodysplastic syndromes
- Research
- Treatments and side-effects
Supporting the advancement of science for Waldenström’s macroglobulinaemia
Research to further scientific knowledge of the cause and treatment of the uncommon type of blood cancer, Waldenström’s macroglobulinaemia (WM), is being co-funded by the Leukaemia Foundation.
- Other blood cancers
- Research
Graeme’s amazing CAR T-cell therapy story – relapse to remission in 28 days
Just 28 days after Graeme Ardern had CAR T-cell therapy, he received the most amazing news - he’d had a complete metabolic response.
- Clinical trials
- Hodgkin lymphoma
Expert Series: physiotherapist Julie Allen works with cancer patients to improve quality of life and survival
When Julie Allen was diagnosed with lymphoma as a young professional mum, she thought she'd go straight back to work after treatment. But afterwards she literally felt “stripped bare”.
- Interviews with experts
- Non-Hodgkin lymphoma
High schooler Megan faces biggest test yet
Megan Reid was about to begin her last two years of high school when she was diagnosed with a blood cancer.
- Hodgkin lymphoma
PBAC considering selinexor for a third time
For the third time, selinexor (Xpovio®) will be considered by the Pharmaceutical Benefits Advisory Committee (PBAC) at its November 2022 meeting for the treatment of relapsed/refractory (R/R) myeloma.
- Myeloma
- Treatments and side-effects
Martin’s setting new records for remission and enjoying life while living with myeloma
During the 22 years Martin Boling has had myeloma, blood cancer of various types has affected four other members of his family too, not just him.
- Myeloma
